• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PIK3CA基因中两类致癌突变之间的功能差异。

Functional differences between two classes of oncogenic mutation in the PIK3CA gene.

作者信息

Chaussade Claire, Cho Kitty, Mawson Claire, Rewcastle Gordon W, Shepherd Peter R

机构信息

Department of Molecular Medicine, University of Auckland, New Zealand.

出版信息

Biochem Biophys Res Commun. 2009 Apr 17;381(4):577-81. doi: 10.1016/j.bbrc.2009.02.081. Epub 2009 Feb 20.

DOI:10.1016/j.bbrc.2009.02.081
PMID:19233141
Abstract

PIK3CA codes for the p110alpha isoform of class-IA PI 3-kinase and oncogenic mutations in the helical domain and kinase domain are common in several cancers. We studied the biochemical properties of a common helical domain mutant (E545K) and a common kinase domain mutant (H1047R). Both retain the ability to autophosphorylate Ser608 of p85alpha and are also inhibited by a range of PI 3-kinase inhibitors (Wortmannin, LY294002, PI-103 and PIK-75) to a similar extent as WT p110alpha. Both mutants display an increased V(max) but while a PDGF derived diphosphotyrosylpeptide caused an increase in V(max) for WT p85alpha/p110alpha it did not for the E545K variant and actually decreased V(max) for the H1047R variant. Further, the E545K mutant was activated by H-Ras whereas the H1047R mutant was not. Together these results suggest helical domain mutants are in a state mimicking activation by growth factors whereas kinase domain mutants mimic the state activated by H-Ras.

摘要

PIK3CA编码IA类PI 3激酶的p110α亚型,螺旋结构域和激酶结构域中的致癌突变在几种癌症中很常见。我们研究了一种常见的螺旋结构域突变体(E545K)和一种常见的激酶结构域突变体(H1047R)的生化特性。两者都保留了对p85α的Ser608进行自身磷酸化的能力,并且也受到一系列PI 3激酶抑制剂(渥曼青霉素、LY294002、PI-103和PIK-75)的抑制,抑制程度与野生型p110α相似。两种突变体都表现出V(max)增加,但虽然源自血小板衍生生长因子(PDGF)的双磷酸化酪氨酸肽会使野生型p85α/p110α的V(max)增加,但对E545K变体却没有这种作用,实际上对H1047R变体反而降低了V(max)。此外,E545K突变体被H-Ras激活,而H1047R突变体则未被激活。这些结果共同表明,螺旋结构域突变体处于一种模拟生长因子激活的状态,而激酶结构域突变体则模拟被H-Ras激活的状态。

相似文献

1
Functional differences between two classes of oncogenic mutation in the PIK3CA gene.PIK3CA基因中两类致癌突变之间的功能差异。
Biochem Biophys Res Commun. 2009 Apr 17;381(4):577-81. doi: 10.1016/j.bbrc.2009.02.081. Epub 2009 Feb 20.
2
The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations.人源p110α/p85α复合物的结构揭示了致癌性PI3Kα突变的影响。
Science. 2007 Dec 14;318(5857):1744-8. doi: 10.1126/science.1150799.
3
Effects of oncogenic p110alpha subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase.致癌性p110α亚基突变对磷酸肌醇3激酶脂质激酶活性的影响。
Biochem J. 2008 Jan 15;409(2):519-24. doi: 10.1042/BJ20070681.
4
Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.头颈部鳞状细胞癌中PIK3CA基因的致癌突变。
Int J Oncol. 2008 Jan;32(1):101-11.
5
PIK3CA gene mutations in breast carcinoma in Malaysian patients.马来西亚患者乳腺癌中的PIK3CA基因突变
Cancer Genet Cytogenet. 2008 Dec;187(2):74-9. doi: 10.1016/j.cancergencyto.2008.07.005.
6
Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases.脂质结合的调节是 IA 类 PI3-激酶激活机制的基础。
Oncogene. 2012 Aug 9;31(32):3655-66. doi: 10.1038/onc.2011.532. Epub 2011 Nov 28.
7
Oncogenic PI3K deregulates transcription and translation.致癌性PI3K会使转录和翻译失调。
Nat Rev Cancer. 2005 Dec;5(12):921-9. doi: 10.1038/nrc1753.
8
A new evaluation method for quantifying PI3K activity by HTRF assay.一种通过HTRF分析定量PI3K活性的新评估方法。
Biochem Biophys Res Commun. 2008 Dec 19;377(3):941-5. doi: 10.1016/j.bbrc.2008.10.083. Epub 2008 Oct 24.
9
Rare PIK3CA hotspot mutations in carcinomas of the biliary tract.胆道癌中罕见的PIK3CA热点突变。
Genes Chromosomes Cancer. 2008 May;47(5):363-7. doi: 10.1002/gcc.20540.
10
Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase.IA类磷酸肌醇3激酶的螺旋结构域和激酶结构域突变对乳腺癌细胞迁移和转移的差异增强作用
Cancer Res. 2009 Dec 1;69(23):8868-76. doi: 10.1158/0008-5472.CAN-09-1968. Epub 2009 Nov 10.

引用本文的文献

1
Epinephrine inhibits PI3Kα via the Hippo kinases.肾上腺素通过 Hippo 激酶抑制 PI3Kα。
Cell Rep. 2023 Dec 26;42(12):113535. doi: 10.1016/j.celrep.2023.113535. Epub 2023 Dec 4.
2
Structural and mechanistic insights provided by single particle cryo-EM analysis of phosphoinositide 3-kinase (PI3Kα).通过对磷酸肌醇 3-激酶(PI3Kα)的单颗粒冷冻电镜分析提供的结构和机制见解。
Biochim Biophys Acta Rev Cancer. 2023 Sep;1878(5):188947. doi: 10.1016/j.bbcan.2023.188947. Epub 2023 Jun 30.
3
Phase II Study of Copanlisib in Patients With Tumors With Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F.
NCI-MATCH ECOG-ACRIN 试验(EAY131)子方案 Z1F:携带突变的肿瘤患者中 Copanlisib 的 II 期研究结果。
J Clin Oncol. 2022 May 10;40(14):1552-1561. doi: 10.1200/JCO.21.01648. Epub 2022 Feb 8.
4
For Better or Worse: The Potential for Dose Limiting the On-Target Toxicity of PI 3-Kinase Inhibitors.好或坏:限制 PI3K 抑制剂的靶毒性的潜在可能性。
Biomolecules. 2019 Aug 22;9(9):402. doi: 10.3390/biom9090402.
5
APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma.APOBEC 诱导的突变及其对头颈鳞状细胞癌的癌症效应大小。
Oncogene. 2019 May;38(18):3475-3487. doi: 10.1038/s41388-018-0657-6. Epub 2019 Jan 15.
6
Insights into the mechanism of the PIK3CA E545K activating mutation using MD simulations.利用 MD 模拟深入了解 PIK3CA E545K 激活突变的机制。
Sci Rep. 2018 Oct 19;8(1):15544. doi: 10.1038/s41598-018-27044-6.
7
High-throughput screening campaigns against a PI3Kα isoform bearing the H1047R mutation identified potential inhibitors with novel scaffolds.针对携带 H1047R 突变的 PI3Kα 同工型的高通量筛选活动鉴定出了具有新型骨架的潜在抑制剂。
Acta Pharmacol Sin. 2018 Nov;39(11):1816-1822. doi: 10.1038/s41401-018-0057-z. Epub 2018 Jul 10.
8
The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma.IA类磷脂酰肌醇-4,5-二磷酸3-激酶催化亚基在胶质母细胞瘤中的作用
Front Oncol. 2017 Dec 15;7:312. doi: 10.3389/fonc.2017.00312. eCollection 2017.
9
Assessing the subcellular distribution of oncogenic phosphoinositide 3-kinase using microinjection into live cells.通过显微注射到活细胞中来评估致癌性磷酸肌醇3激酶的亚细胞分布。
Biosci Rep. 2014 Apr 1;34(2). doi: 10.1042/BSR20130133.
10
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes.2,433 例乳腺癌的体细胞突变图谱细化了其基因组和转录组景观。
Nat Commun. 2016 May 10;7:11479. doi: 10.1038/ncomms11479.